Align Tech (ALGN) AI Stock Analysis
Align Tech
(BMV:ALGN)
No summary available
Align Tech (ALGN) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- MXN 10.65B
- Dividend Yield
- ―
- Average Volume (3M)
- 50
- Price to Earnings (P/E)
- 21.8
- Beta (1Y)
- -0.11
- Revenue Growth
- -6.35%
- EPS Growth
- 19.16%
- Country
- Mexico
- Employees
- 20,290
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Align Tech Business Overview & Revenue Model
Company Description
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wid...
Align Tech Earnings Call Summary
The call was positive overall. Align reported record Clear Aligner shipments and doctor submitters, broad international growth, improved utilization, stronger operating margins, healthy cash generation and continued investment in digital workflows and 3D-printing innovation. These strengths outweighed the lowlights, which included a challenging consumer environment, lower Systems and Services revenue, ASP and mix pressure, North American GP retail weakness, foreign exchange effects and reduced fourth-quarter revenue assumptions.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For Q4 2026, assuming no circumstances occur beyond our control that could impact our business, Align expects worldwide revenues in the range of $1 billion to $1.020 billion, Clear Aligner volume to be up low single digits year-over-year, Clear Aligner ASP to be down approximately 1% year-over-year, Systems and Services revenue in the range of $170 million to $180 million, GAAP gross margin of approximately 71%, non-GAAP gross margin of approximately 72%, GAAP operating margin of approximately 20%, non-GAAP operating margin of approximately 26%, and to repurchase up to $300 million of common stock; for fiscal 2026, it expects worldwide revenue of approximately $4.11 billion to $4.13 billion, Clear Aligner volume and revenue growth up approximately 5% to 6% year-over-year, Clear Aligner ASP slightly below 2025, Systems and Services revenue of $715 million to $725 million, GAAP operating margin of approximately 16.2%, up approximately 2.7 points year-over-year, non-GAAP operating margin of approximately 23.7%, representing approximately 100 basis point improvement year-over-year, capital expenditures of approximately $125 million to $150 million, and approximately $500 million of common-stock repurchases; for 2027, Align expects another year of revenue growth and margin expansion, continued Invisalign volume growth, record doctor submitters, improving utilization, a broadly stable Clear Aligner pricing environment with ASP slightly down, Systems and Services revenue growth with solid unit growth and stable ASPs, and at least another 100 basis points of non-GAAP operating margin improvement, with preliminary planning assuming an operating environment broadly consistent with current conditions and not requiring a consumer recovery.
Align Tech Risk Analysis
Align Tech disclosed 37 risk factors in its most recent earnings report. Align Tech reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
1 New RiskAlign Tech Peers Comparison
Overall Rating
INMD75Outperform
GEHC71Outperform
PHG69Neutral
BFLY67Neutral
VREX57Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | $760.73M | 10.58 | 11.80% | ― | -6.71% | -50.25% | |
| 71Outperform | $34.62B | 19.84 | 16.13% | 0.19% | 6.87% | -2.26% | |
| 69Neutral | $26.31B | 20.72 | 10.05% | 3.68% | ― | ― | |
| 67Neutral | $1.70B | -30.52 | -28.22% | ― | 39.35% | 38.09% | |
| 57Neutral | $782.60M | 35.10 | 4.60% | ― | 5.31% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MX:ALGN | Align Technology | 2500.00 | -25.00 | -0.99% | |
| PHG | Koninklijke Philips N.V. | 26.92 | 0.58 | 2.19% | |
| VREX | Varex Imaging Corporation | 18.43 | 6.39 | 53.07% | |
| INMD | Inmode | 13.22 | -1.47 | -10.01% | |
| BFLY | Butterfly Network, Inc. | 6.39 | 3.48 | 119.59% | |
| GEHC | Ge Healthcare Technologies Inc. | 76.57 | 2.25 | 3.03% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.